Interestingly, we observed that Smad 7, which prevents Smad 2/3 phosphorylation and promotes the formation of the ActRIIB complex, was significantly upregulated in soleus muscle from control and MetS rats treated with R+Q as compared to groups without treatment. This evidence concerns the gene ACVR2B and metabolic syndrome.